Choy Gavin 4
4 · GT Biopharma, Inc. · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Choy Gavin
Acting Chief Financial Officer
Transactions
- Award
Option to purchase Common Stock
2021-12-31+227,500→ 227,500 totalExercise: $3.05Exp: 2031-12-31→ Common Stock (227,500 underlying)
Footnotes (1)
- [F1]33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control.